구강내 발생한 다발성 정맥기형 병소에의 Ethanolamine Oleate 경화제 주사 후 치험례 = Sclerotherapy of Multiple Intraoral Venous Malformations with Use of Ethanolamine Oleate: A Case Report

다국어 초록 (Multilingual Abstract)

Hemangioma and vascular malformation are the most common benign tumors that are caused by congenitally or traumatic events. Theses tumors represent approximately 1/3~1/4 of all hemangiomas and vascular malformations in the head and neck. There are many forms of treatment for hemangioma and vascular malformation including closed observation, surgery, radiotherapy, laser therapy, steroid therapy, compression, embolization, and sclerotherapy. Ethanolamine oleate is an unsaturated fatty acid salt that has been used as a sclerosing agent because of its excellent thrombosing properties. This paper presents 1 case of intraoral multiple venous malformations treatment with 1.25% ethanolamine oleate (3.6~9.6 mg dose) intralesionally injected for 6 to 14 weeks over 2 week intervals. After the sclerotherapy, lesions almost completely disappeared without side effects. In conclusion, sclerotherapy using ethanolamine oleate is very effective against venous malformations, and sufficiently provides alternative support for surgical and other methods.

참고문헌 (Reference)

1 이은영, "하순에 발생한 혈관종 환자의 치험례" 대한악안면성형재건외과학회 32 (32): 373-377, 2010

2 김경욱, "경화제 투여요법을 이용한 구강 내 양성혈관병소에 대한 치험례" 대한구강악안면외과학회 36 (36): 280-285, 2010

3 Madewell JE, "Tumors and tumor-like lesions in or about joints, In Diagnosis of bone and joint disorders. Vol. 6. 3rd ed" WB Saunders 3939-3990, 1995

4 Chin DC, "Treatment of maxillary hemangioma with a sclerosing agent" 55 : 247-249, 1983

5 Matsumoto K, "Sclerotherapy of hemangioma with late involution" 29 : 668-671, 2003

6 Johann AC, "Sclerotherapy of benign oral vascular lesion with ethanolamine oleate: an open clinical trial with 30 lesions" 100 : 579-584, 2005

7 Sadeghi E, "Oral hemangioma treated with a sclerosing agent. Report of a case" 18 : 262-263, 1989

8 Neville BW, "Oral & maxillofacial pathology. 3rd ed" W.B. Saunders 539-543, 2009

9 Connor WE, "Massive thrombosis produced by fatty acid infusion" 42 : 860-866, 1963

10 Tyagi I, "Management of low-flow vascular malformations of upper aero digestive system-role of N-butyl cyanoacrylate in peroperative devascularization" 44 : 152-156, 2006

11 Yakes WF, "How I do it. Arteriovenous malformation management" 19 : 65-71, 1996

12 Mulliken JB, "Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics" 69 : 412-422, 1982

13 Beckelheimer RG, "Hemangioma of the tongue" 36 : 144-145, 1988

14 Wolff K, "Fitzpatrick's dermatology in general medicine. 7th ed" McGraw Hill 1164-, 2008

15 최영호, "Craniofacial cavernous venous malformations: Percutaneous sclerotherapy with use of ethanolamine oleate" LIPPINCOTT WILLIAMS WILKINS 13 (13): 475-482, 200205

16 Zou ZJ, "Clinical application of angiography of oral and maxillofacial hemangiomas. Clinical analysis of seventy cases" 55 : 437-447, 1983

17 Watson WL, "Blood and lymph vessel tumors. A report of 1056 cases" 71 : 569-588, 1940

18 Bordas JM, "Anaphylactic reaction to ethanolamine oleate injection in sclerotherapy of esophageal varices" 21 : 50-, 1989

19 Nishida R, "A sclerosant with astringent properties developed in China for oesophageal varices: comparison with ethanolamine oleate and polidocanol" 14 : 481-488, 1999

20 Baurmash H, "A conservative approach to the management of orofacial vascular lesions in infants and children: report of cases" 49 : 1222-1225, 1991